287 related articles for article (PubMed ID: 15191384)
1. Potential risk factors for infection with Candida spp. in critically ill patients.
Peres-Bota D; Rodriguez-Villalobos H; Dimopoulos G; Melot C; Vincent JL
Clin Microbiol Infect; 2004 Jun; 10(6):550-5. PubMed ID: 15191384
[TBL] [Abstract][Full Text] [Related]
2. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
[TBL] [Abstract][Full Text] [Related]
3. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
5. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
Dimopoulos G; Ntziora F; Rachiotis G; Armaganidis A; Falagas ME
Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
[TBL] [Abstract][Full Text] [Related]
6. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
7. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata.
Blot S; Vandewoude K; Hoste E; Poelaert J; Colardyn F
J Hosp Infect; 2001 Apr; 47(4):308-13. PubMed ID: 11289775
[TBL] [Abstract][Full Text] [Related]
8. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality].
Acar A; Oncül O; Küçükardali Y; Ozyurt M; Haznedaroğlu T; Cavuşlu S
Mikrobiyol Bul; 2008 Jul; 42(3):451-61. PubMed ID: 18822889
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
Davis SL; Vazquez JA; McKinnon PS
Ann Pharmacother; 2007 Apr; 41(4):568-73. PubMed ID: 17374623
[TBL] [Abstract][Full Text] [Related]
11. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
Husain S; Tollemar J; Dominguez EA; Baumgarten K; Humar A; Paterson DL; Wagener MM; Kusne S; Singh N
Transplantation; 2003 Jun; 75(12):2023-9. PubMed ID: 12829905
[TBL] [Abstract][Full Text] [Related]
12. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Candida tropicalis fungemia in patients with cancer.
Kontoyiannis DP; Vaziri I; Hanna HA; Boktour M; Thornby J; Hachem R; Bodey GP; Raad II
Clin Infect Dis; 2001 Nov; 33(10):1676-81. PubMed ID: 11568858
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
Nace HL; Horn D; Neofytos D
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):289-94. PubMed ID: 19376670
[TBL] [Abstract][Full Text] [Related]
16. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
[TBL] [Abstract][Full Text] [Related]
17. [The preemptive treatment of invasive Candida infection with reference of corrected colonization index in critically ill patients: a multicenter, prospective, randomized controlled clinical study].
Wang DH; Gao XJ; Wei LQ; Xia R; Sun L; Li Q; Peng M; Qin YZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):525-8. PubMed ID: 19751559
[TBL] [Abstract][Full Text] [Related]
18. Use of multilocus sequence typing for the investigation of colonisation by Candida albicans in intensive care unit patients.
Cliff PR; Sandoe JA; Heritage J; Barton RC
J Hosp Infect; 2008 May; 69(1):24-32. PubMed ID: 18396349
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
20. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
Safdar A; Bannister TW; Safdar Z
Int J Infect Dis; 2004 May; 8(3):180-6. PubMed ID: 15109594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
